Provided by Tiger Fintech (Singapore) Pte. Ltd.

PTC Inc

176.11
+2.181.25%
Post-market: 176.530.4200+0.24%18:23 EST
Volume:1.20M
Turnover:209.92M
Market Cap:21.10B
PE:28.68
High:176.77
Open:173.21
Low:172.03
Close:173.93
52wk High:219.69
52wk Low:133.38
Shares:119.79M
Float Shares:119.32M
Volume Ratio:0.86
T/O Rate:1.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):6.14
EPS(LYR):6.18
ROE:21.03%
ROA:9.68%
PB:5.50
PE(LYR):28.52

Loading ...

PTC Inc: FY'26 Guidance for Constant Currency Arr Growth of 7% to 9%

THOMSON REUTERS
·
Nov 06

PTC Inc: Increasing Share Repurchases Under Our $2 Bln Authorization, With About $200 Mln Expected in Q1'26

THOMSON REUTERS
·
Nov 06

PTC Announces Fourth Fiscal Quarter and Full Fiscal Year 2025 Results

THOMSON REUTERS
·
Nov 06

TPG to Acquire PTC's Industrial Connectivity and Iot Businesses

THOMSON REUTERS
·
Nov 06

Cantor Fitzgerald Sticks to Its Buy Rating for PTC Therapeutics (PTCT)

TIPRANKS
·
Nov 05

PTC Therapeutics Is Maintained at Overweight by Wells Fargo

Dow Jones
·
Nov 05

RBC Capital Adjusts PTC Therapeutics Price Target to $82 From $70, Maintains Outperform Rating

MT Newswires Live
·
Nov 05

PTC Therapeutics (PTCT) Gets a Buy from Truist Financial

TIPRANKS
·
Nov 05

PTC Therapeutics price target raised to $80 from $68 at JPMorgan

TIPRANKS
·
Nov 05

GUIDANCE: (PTCT) PTC Therapeutics Expects Full Year 2025 Revenue Range $750M - $800M, vs. FactSet Est of $1.73B

MT Newswires Live
·
Nov 05

Earnings Flash (PTCT) PTC Therapeutics Posts Q3 EPS $0.20, vs. FactSet Est of $1.13 Loss

MT Newswires Live
·
Nov 05

PTC Therapeutics Q3 EPS $0.20 Beats $(1.42) Estimate, Sales $211.007M Beat $185.251M Estimate

Benzinga
·
Nov 05

PTC Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Nov 04

Truist sees no read-throughs to PTC, Wave Life from uniQure news

TIPRANKS
·
Nov 04

Enlight Secures Nearly $150 Million in Tax Equity Financing for Quail Ranch

GlobeNewswire
·
Nov 03

How Investors May Respond To PTC Therapeutics (PTCT) Analysts' Optimism on Sephience Launch Momentum

Simply Wall St.
·
Oct 31

PTC Is Maintained at Buy by Rosenblatt

Dow Jones
·
Oct 30

PTC Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Oct 30

PTC Therapeutics Is Maintained at Buy by Jefferies

Dow Jones
·
Oct 29

Citigroup Adjusts Price Target on PTC to $205 From $206, Maintains Neutral Rating

MT Newswires Live
·
Oct 24